Critic at Large

» cancer and opinion

Most Recent

Measuring PD-L1 levels was a great start. Now we need to quantify more protein biomarkers, assess the tumor mutational landscape, and examine immune cell signatures, too.

0 Comments

image: Pet Scans

Pet Scans

By , , and | April 1, 2016

Studying tumor development and treatment in dogs and cats, in parallel with research on rodents and humans, could improve the successful translation of new cancer drugs.

0 Comments

image: Control ALT, Delete Cancer

Control ALT, Delete Cancer

By , , and | April 1, 2015

Treating cancer by shutting down the alternative lengthening of telomeres (ALT) pathway

1 Comment

image: The Challenges of Precision

The Challenges of Precision

By | April 1, 2015

Researchers face roadblocks to treating an individual patient’s cancer as a unique disease.

1 Comment

image: Fighting Cancer with Nanomedicine

Fighting Cancer with Nanomedicine

By | April 1, 2014

Nanotechnology-based therapeutics will revolutionize cancer treatment.

2 Comments

image: Researchers, Hire Hackers

Researchers, Hire Hackers

By | May 1, 2013

Clinical researchers need programming support to streamline their work, minimize error in the data, and find new trends that can point to better treatments.

0 Comments

image: Cancer Clinical Trials of Tomorrow

Cancer Clinical Trials of Tomorrow

By | April 1, 2013

Advances in genomics and cancer biology will alter the design of human cancer studies.

0 Comments

image: Variety Is the Spice of Life

Variety Is the Spice of Life

By | February 1, 2013

True understanding of the complexity of biological systems demands an assortment of model systems.

2 Comments

image: Stress Tests

Stress Tests

By | September 1, 2012

Judiciously applied pressure could benefit the scientific system by providing an opportunity for renewal.

4 Comments

image: Cooking Up Creative Solutions

Cooking Up Creative Solutions

By | May 1, 2012

More collaborators and more data are the key ingredients.

0 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. March for Science: Dispatches from Washington, DC
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS